Download PDF
Planta Med 2011; 77(18): 1970-1976
DOI: 10.1055/s-0031-1280129
Biological and Pharmacological Activity
Original Papers
© Georg Thieme Verlag KG Stuttgart · New York

Effects of Insulin and St. John's Wort Treatments on Anxiety, Locomotory Activity, Depression, and Active Learning Parameters of Streptozotocin-Diabetic Rats

Özgür Devrim Can1 , Yusuf Öztürk1 , Ümide Demir Özkay1
  • 1Department of Pharmacology, Faculty of Pharmacy, Anadolu University, Eskisehir, Turkey
Further Information

Publication History

received April 4, 2011 revised June 27, 2011

accepted July 1, 2011

Publication Date:
19 August 2011 (online)

    Permissions and Reprints

Abstract

The aim of this work was to investigate the effects of St. John's Wort (SJW) extract treatment on behavioral changes arising in streptozotocin (STZ)-diabetic rats. Plus-maze, activity cage, modified forced swimming, and active avoidance tests were performed for evaluating exploratory behaviors, spontaneous locomotor activities, depression levels, and learning parameters of animals, respectively. Obtained data exhibited a diabetes mellitus (DM)-induced increase in anxiety and depression levels, decrease in spontaneous locomotor activities, and impairment of learning parameters in rats even in the early stages of the disease. Daily insulin replacement (2 IU/kg/day) could not restore these impaired parameters completely, indicating the need of novel therapeutic approaches. SJW extract (125 and 250 mg/kg) treatments for seven days provided significant improvement in all of the impaired parameters observed in this study, probably due to its antidiabetic and central nervous system (CNS)-related effects.

Based on the findings of the present study, it may be suggested that SJW extracts may be of help to diabetic patients suffering from depressive moods, sleeping disturbances, and cognitive deficits and may provide a new potential alternative for the treatment of psychiatric complications of diabetes.

Key words

diabetes mellitus - Hypericum perforatum Linn. - Clusiaceae - insulin - modified forced swimming test - plus maze - avoidance

References

  • 1 World Health Organization .Department of noncommunicable disease surveillance, definition, diagnosis and classification of Diabetes mellitus and its complications. Geneva: World Health Organization; 1999: 1-57
    Google Scholar
  • 2 Li Z G, Sima A A. C-peptide and central nervous system complications in diabetes.  Exp Diabesity Res. 2004;  5 79-90
    CrossrefPubMedGoogle Scholar
  • 3 Linde K. St. John's wort – an overview.  Forsch Komplementmed. 2009;  16 146-155
    PubMedGoogle Scholar
  • 4 Holsboer-Trachsler E. Phytotherapeutic drugs and sleep.  Schweiz Rundsch Med Prax. 2000;  89 2178-2182
    PubMedGoogle Scholar
  • 5 Rang H P, Dale M M, Ritterb J M. Pharmacology. London: Churchill Livingstone; 2003: 492-499
    Google Scholar
  • 6 Kasper S, Caraci F, Forti B, Drago F, Aguglia E. Efficacy and tolerability of Hypericum extract for the treatment of mild to moderate depression.  Eur Neuropsychopharmacol. 2010;  20 747-765
    CrossrefPubMedGoogle Scholar
  • 7 Crupi R, Mazzon E, Marino A, La Spada G, Bramanti P, Battaglia F, Cuzzocrea S, Spina E. Hypericum perforatum treatment: effect on behaviour and neurogenesis in a chronic stress model in mice.  BMC Complement Alternat Med. 2011;  11 7
    PubMedGoogle Scholar
  • 8 Can O D, Öztürk Y, Öztürk N, Sagratini G, Ricciutelli M, Vittori S, Maggi F. Effects of treatment with St. John's wort on blood glucose levels and pain perceptions of streptozotocin-diabetic rats.  Fitoterapia. 2011;  82 576-584
    CrossrefPubMedGoogle Scholar
  • 9 Romanovsky D, Cruz N F, Dienel G A, Dobretsov M. Mechanical hyperalgesia correlates with insulin deficiency in normoglycemic streptozotocin-treated rats.  Neurobiol Dis. 2006;  24 384-394
    CrossrefPubMedGoogle Scholar
  • 10 Zanoli L P, Rivasi M, Zavatti M, Brusiani F, Baraldi M. New insight in the neuropharmacological activity of Humulus lupulus.  J Ethnopharmacol. 2005;  102 102-106
    CrossrefPubMedGoogle Scholar
  • 11 Palenicek T, Votava M, Bubenikova V, Horacek J. Increased sensitivity to the acute effects of MDMA (“ecstasy”) in female rats.  Physiol Behav. 2005;  86 546-553
    CrossrefPubMedGoogle Scholar
  • 12 Cryan J F, Markou A, Lucki I. Assessing antidepressant activity in rodents: recent developments and future need.  Trends Pharmacol Sci. 2002;  23 238-245
    CrossrefPubMedGoogle Scholar
  • 13 Sanchez D J, Colomina M T, Domingo J L. Effects of vanadium on activity and learning in rats.  Physiol Behav. 1998;  63 345-350
    CrossrefPubMedGoogle Scholar
  • 14 Zapata-Sudo G, Mendes T C, Kartnaller M A, Fortes T O, Freitas N F, Kaplan M A, Sudo R T. Sedative and anticonvulsant activities of methanol extract of Dorstenia arifolia in mice.  J Ethnopharmacol. 2010;  130 9-12
    CrossrefPubMedGoogle Scholar
  • 15 Fernández S P, Wasowski C, Loscalzo L M, Granger R E, Johnston G A, Paladini A C, Marder M. Central nervous system depressant action of flavonoid glycosides.  Eur J Pharmacol. 2006;  539 168-176
    CrossrefPubMedGoogle Scholar
  • 16 Girzu M, Carnat A, Privat A M, Fialip J, Carnat A P, Lamaison J L. Sedative activity in mice of a hydroalcohol extract of Hypericum perforatum L.  Phytother Res. 1997;  11 395-397
    CrossrefPubMedGoogle Scholar
  • 17 Butterweck V, Wall A, Lieflander-Wulf U, Winterhoff H, Nahrstedt A. Effects of the total extract and fractions of Hypericum perforatum in animal assays for antidepressant activity.  Pharmacopsychiatry. 1997;  30 117-124
    Article in Thieme ConnectPubMedGoogle Scholar
  • 18 Khalifa A E. Hypericum perforatum as a nootropic drug: enhancement of retrieval memory of a passive avoidance conditioning paradigm in mice.  J Ethnopharmacol. 2001;  76 49-57
    CrossrefPubMedGoogle Scholar
  • 19 Ramanathan M, Jaiswal A K, Bhattacharya S K. Differential effects of diazepam on anxiety in streptozotocin induced diabetic and non-diabetic rats.  Psychopharmacology. 1998;  135 361-367
    CrossrefPubMedGoogle Scholar
  • 20 Hilakivi-Clarke L A, Wozniak K M, Durcan M J, Linnoila M. Behavior of streptozotocin-diabetic mice in tests of exploration, locomotion, anxiety, depression and aggression.  Physiol Behav. 1990;  48 429-433
    CrossrefPubMedGoogle Scholar
  • 21 Szkudelski T. The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.  Physiol Res. 2001;  50 537-546
    PubMedGoogle Scholar
  • 22 Merali Z, Ahmad Q, Veitch J. Behavioural and neurochemical profile of the spontaneously diabetic Wistar BB rat.  Behav Brain Res. 1988;  29 51-60
    CrossrefPubMedGoogle Scholar
  • 23 Howarth F C, Jacobson M, Shafiullah M, Adeghate E. Effects of insulin treatment on heart rhythm, body temperature and physical activity in streptozotocin-induced diabetic rat.  Clin Exp Pharmacol Physiol. 2006;  33 327-331
    CrossrefPubMedGoogle Scholar
  • 24 Biessels G J, Kamal A, Urban I J, Spruijt B M, Erkelens D W, Gispen W H. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: effects of insulin treatment.  Brain Res. 1998;  800 125-135
    CrossrefPubMedGoogle Scholar
  • 25 Sima A A F, Kamiya H, Li Z G. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes.  Eur J Pharmacol. 2004;  490 187-197
    CrossrefPubMedGoogle Scholar
  • 26 Hasanein P, Shahidi S. Effects of Hypericum perforatum extract on diabetes-induced learning and memory impairment in rats.  Phytother Res. 2011;  25 544-549
    CrossrefPubMedGoogle Scholar
  • 27 Nassiri-Asl M, Shariati-Rad S, Zamansoltani F. Anticonvulsive effects of intracerebroventricular administration of rutin in rats.  Prog Neuropsychopharmacol Biol Psychiatry. 2008;  32 989-993
    CrossrefPubMedGoogle Scholar
  • 28 Fernandes A A, Novelli E L, Okoshi K, Okoshi M P, Di Muzio B P, Guimarães J F, Fernandes Junior A. Influence of rutin treatment on biochemical alterations in experimental diabetes.  Biomed Pharmacother. 2010;  64 214-219
    CrossrefPubMedGoogle Scholar
  • 29 Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard J F, Gross R, Petit P, Bataille D, Oiry C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway.  Br J Pharmacol. 2010;  161 799-814
    CrossrefPubMedGoogle Scholar
  • 30 Anjaneyulu M, Chopra K, Kaur I. Antidepressant activity of quercetin, a bioflavonoid, in streptozotocin-induced diabetic mice.  J Med Food. 2003;  6 391-395
    CrossrefPubMedGoogle Scholar
  • 31 Bhutada P, Mundhada Y, Bansod K, Bhutada C, Tawari S, Dixit P, Mundhada D. Ameliorative effect of quercetin on memory dysfunction in streptozotocin-induced diabetic rats.  Neurobiol Learn Mem. 2010;  94 293-302
    CrossrefPubMedGoogle Scholar
  • 32 Doris A, Ebmeier K, Shajahan P. Depressive illness.  Lancet. 1999;  354 1369-1375
    CrossrefPubMedGoogle Scholar
  • 33 Khoza S, Barner J C. Glucose dysregulation associated with antidepressant agents: an analysis of 17 published case reports.  Int J Clin Pharm. 2011;  33 484-492
    CrossrefPubMedGoogle Scholar
  • 34 Derijks H J, Meyboom R H, Heerdink E R, De Koning F H, Janknegt R, Lindquist M, Egberts A C. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports.  Eur J Clin Pharmacol. 2008;  64 531-538
    CrossrefPubMedGoogle Scholar

Özgür Devrim Can

Department of Pharmacology
Anadolu University, Faculty of Pharmacy

Tepebaşı

26470 Eskisehir

Turkey

Phone: +90 222 3 35 05 80 ext. 37 49

Fax: +90 222 3 35 07 50

Email: ozgurdt@anadolu.edu.tr

      >